HC Wainwright Brokers Lower Earnings Estimates for TRVI
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Equities researchers at HC Wainwright lowered their Q3 2025 earnings per share estimates for Trevi Therapeutics in a research report issued on Wednesday, March 19th. HC Wainwright analyst O. Livnat now forecasts that the company will earn ($0.10) per share for the quarter, down from their prior […]
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Equities researchers at HC Wainwright lowered their Q3 2025 earnings per share estimates for Trevi Therapeutics in a research report issued on Wednesday, March 19th. HC Wainwright analyst O. Livnat now forecasts that the company will earn ($0.10) per share for the quarter, down from their prior […]
